These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8651837)

  • 21. Postmenopausal hormone replacement therapy: scientific review.
    Nelson HD; Humphrey LL; Nygren P; Teutsch SM; Allan JD
    JAMA; 2002 Aug; 288(7):872-81. PubMed ID: 12186605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Older women and hormone replacement therapy: factors influencing late life initiation.
    Leveille SG; LaCroix AZ; Newton KM; Keenan NL
    J Am Geriatr Soc; 1997 Dec; 45(12):1496-500. PubMed ID: 9400560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multicentric study regarding the use of hormone therapy during female mid-age (REDLINC VI).
    Blümel JE; Chedraui P; Barón G; Benítez Z; Flores D; Espinoza MT; Gomez G; González E; Hernández L; Lima S; Martino M; Montaño A; Monterrosa A; Mostajo D; Ojeda E; Onatra W; Robles C; Saavedra J; Sánchez H; Tserotas K; Vallejo MS; Vallejo C;
    Climacteric; 2014 Aug; 17(4):433-41. PubMed ID: 24443950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Moderate dosage estrogen-androgen therapy improves continuation rates in postmenopausal women: impact of the WHI reports.
    Gambrell RD; Natrajan PK
    Climacteric; 2006 Jun; 9(3):224-33. PubMed ID: 16766436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prevalence of oestrogen replacement therapy in South Australia.
    MacLennan AH; MacLennan A; Wilson D
    Maturitas; 1993 May; 16(3):175-83. PubMed ID: 8515717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Menopausal symptom management and prevention counseling after the Women's Health Initiative among women seen in an internal medicine practice.
    Schonberg MA; Wee CC
    J Womens Health (Larchmt); 2005; 14(6):507-14. PubMed ID: 16115005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perceptions of and attitudes toward estrogen therapy among surgically menopausal women in Taiwan.
    Chen RJ; Chang TC; Chow SN
    Menopause; 2008; 15(3):517-23. PubMed ID: 18188137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors predicting current use of hormone replacement therapy among menopausal Jewish women in Israel. The National Women's Health Interview Survey, 1998.
    Merom D; Ifrah A; Cohen-Manheim I; Chinich A; Green MS
    Isr Med Assoc J; 2002 Sep; 4(9):671-6. PubMed ID: 12440227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.
    Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD;
    Menopause; 2000; 7(4):273-81. PubMed ID: 10914621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Menopausal hormone therapy--benefits, adverse reactions, concerns and information sources in 2009.
    Tiihonen M; Saarela M; Saarinen S; Ahonen R; Heikkinen AM
    Maturitas; 2011 Sep; 70(1):69-73. PubMed ID: 21723053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term estrogen and hormone replacement therapy for the prevention and treatment of osteoporosis.
    Levine JP
    Curr Womens Health Rep; 2003 Jun; 3(3):181-6. PubMed ID: 12734027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Women's EMPOWER Survey: Women's Knowledge and Awareness of Treatment Options for Vulvar and Vaginal Atrophy Remains Inadequate.
    Krychman M; Graham S; Bernick B; Mirkin S; Kingsberg SA
    J Sex Med; 2017 Mar; 14(3):425-433. PubMed ID: 28202319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selection to postmenopausal therapy by women's characteristics.
    Hemminki E; Malin M; Topo P
    J Clin Epidemiol; 1993 Mar; 46(3):211-9. PubMed ID: 8455045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spanish post-menopausal women's viewpoints on hormone therapy.
    Castelo-Branco C; Ferrer J; Palacios S; Cornago S; Peralta S
    Maturitas; 2007 Apr; 56(4):420-8. PubMed ID: 17174045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women.
    Rodriguez C; Patel AV; Calle EE; Jacob EJ; Thun MJ
    JAMA; 2001 Mar; 285(11):1460-5. PubMed ID: 11255422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Women's attitudes to hormone replacement therapy, alternative therapy and sexual health: a web-based survey.
    Cumming GP; Herald J; Moncur R; Currie H; Lee AJ
    Menopause Int; 2007 Jun; 13(2):79-83. PubMed ID: 17540139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does estrogen adequately protect postmenopausal women against osteoporosis: an iconoclastic perspective.
    Orwoll ES; Nelson HD
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1872-4. PubMed ID: 10372678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Timing of postmenopausal estrogen for optimal bone mineral density. The Rancho Bernardo Study.
    Schneider DL; Barrett-Connor EL; Morton DJ
    JAMA; 1997 Feb; 277(7):543-7. PubMed ID: 9032160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transdermal hormone therapy and the risk of stroke and venous thrombosis.
    Speroff L
    Climacteric; 2010 Oct; 13(5):429-32. PubMed ID: 20670199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hormone replacement therapy in general practice: a survey of doctors in the MRC's general practice research framework.
    Wilkes HC; Meade TW
    BMJ; 1991 Jun; 302(6788):1317-20. PubMed ID: 2059689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.